Inc has resumed taking orders for its Model 3 long-range version in the United States, the company’s website showed late on Tuesday, after a temporary halt last year due to delivery backlogs. The long-range version of the entry-level Model 3 is priced at $47,240 currently, about 18.5% less than the $57,990 it was priced at last August when Tesla halted taking orders in the U.S. and Canada. “Waitlist is too long. Will enable again as we ramp production,” Chief Executive Officer Elon Musk tweeted at that time in response to a user’s inquiry about the discontinuation of orders. Tesla expects to resume delivery of the long-range Model 3 electric sedan in June, according to the website. However, it is still not accepting orders in Canada, the website showed. The long-range version of the entry-level Model 3 has a range of more than 325 miles (523 kilometers) on a single charge. To boost sales, Tesla has been regularly modifying the prices of its vehicles since the start of this year. After reducing prices earlier, the company slightly increased them on Tuesday in Canada, China, Japan, and the United States. Musk has said Tesla is willing to sacrifice margin for sales volume in the face of a weak economy, but is also looking to move prices back higher, where it can, to match deliveries with output.
Related Articles
Russia’s War On Ukraine Latest: Ukraine Retakes Land Around Bathmat
Moscow acknowledged on Friday that its forces had fallen back north of Ukraine’s battlefield city of Bakhmut after a new offensive, in a retreat that the head of Russia’s Wagner private army called a rout. CONFLICT Russian-installed officials on Friday said missiles fired by Ukrainian forces had injured six children and a Russian parliamentarian and […]
Bank Slide Deepens As SVB Contagion Fear Rattles Markets
Asia’s share markets slid on Tuesday, with financial stocks in Tokyo leading losses as fear of a U.S. banking crisis had investors fleeing the sector and slashing the interest rate outlook even ahead of U.S. inflation data due later in the day. Japan’s Nikkei dropped 2%. The Tokyo Stock Exchange banks index fell more than […]
AstraZeneca Q4 Core Earnings Beat Estimates Despite Esing COVID Vaccine Demand
AstraZeneca PLC (LON:AZN) posted better-than-expected core income in the fourth quarter, thanks to strong demand for its cancer and rare disease therapies that helped make up for waning sales of its COVID-19 vaccine. Core earnings per share during the three months ended on December 31 was $1.38, a drop in actual terms of 17% compared […]